Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2020
Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective studyHyung-Don Kim, Yeonghak Bang, Myung Ah Lee, et al.
Therapeutic Advances in Medical Oncology|May 23, 2022
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysisYeong Hak Bang, Choong-Kun Lee, Changhoon Yoo, et al.
Nature Medicine|February 20, 2024
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trialHyung-Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Plos One|March 3, 2022
Clinical findings, viral load, and outcomes of COVID-19: Comparison of patients with negative and positive initial chest computed tomographyCherry Kim, Ji-Yeon Kim, Eun Joo Lee, et al.
NPJ Precision Oncology|December 11, 2025
Differential implications of tumor endothelial cell and lymphocyte densities in advanced hepatocellular carcinoma patients treated with immunotherapyGwangil Kim, Beodeul Kang, Jung Yong Hong, et al.
JCO Oncology Practice|August 25, 2022
Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer CenterEun Hee Jung, Si Won Lee, Yu Jung Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2026
EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in HER2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction CancerIzuma Nakayama, Min-Hee Ryu, Sung Hee Lim, et al.
Clinical and Molecular Hepatology|December 28, 2025
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancerDaeseong Kim, Nam Suk Sim, Seonjeong Woo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 13, 2025
Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence VariabilityHyunchul Kim, Jinhyung Heo, Soo Ick Cho, et al.
Clinical and Molecular Hepatology|October 28, 2025
Integrative Multi-Omics Profiling Identifies Infiltrative HCC as an Immunotherapy-Resistant Subtype with Distinct Molecular FeaturesWon Suk Lee, Seonjeong Woo, Sung Hwan Lee, et al.
Pageof 10